PedAM
Pediatric Disease Annotations & Medicines
| Disease | herpes simplex infections |
| Phenotype | C0009402|colorectal cancer |
| Sentences | 1 |
| PubMedID- 20486770 | This multicenter phase i/ii study evaluated the safety, pharmacokinetics, and antitumor effects of repeated doses of nv1020, a genetically engineered oncolytic herpes simplex virus, in patients with advanced metastatic colorectal cancer (mcrc). |
Page: 1